NEOGENOMICS INC

NEO

NEOGENOMICS INC

NEO

Insider Sentiment (TTM):

Last Purchase:2025-08-06Last Sale:2026-06-15Shares Purchased (TTM):37,900Shares Sold (TTM):58,576

Institutional Sentiment:

As of:2026-03-31Institutional Shares Owned:129,796,268Shares Outstanding:129,166,000Institutional Ownership Pct.:100.49%

Earnings Market Reaction:

Filing Date:2026-04-28Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Companies in Services-Testing Laboratories

ULS AIDX BNBX FUNI

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30
Assets
Assets Current
Cash And Cash Equivalents At Carrying Value	146	160	164	155	346	367	362	355	332	342	306	289
Debt Securities Available For Sale Excluding Accru…	-	0	0	9	12	20	26	33	53	73	96	120
Accounts Receivable Net Current	167	159	155	153	151	151	151	147	140	131	133	125
Inventory Net	30	29	28	34	30	27	24	23	20	24	24	25
Prepaid Expense Current	24	21	22	23	23	20	18	17	19	18	19	17
Other Assets Current	7	7	11	10	12	12	8	9	9	8	9	8
Assets Held For Sale Not Part Of Disposal Group Cu…	-	-	2	9	-	-	-	-	-	-	-	-
Assets Current	374	376	382	393	574	596	590	584	574	597	587	585
Property Plant And Equipment Net	84	85	85	85	90	94	93	92	88	92	95	100
Operating Lease Right Of Use Asset	77	78	80	83	78	80	81	84	87	92	87	91
Intangible Assets Net Excluding Goodwill	279	287	294	302	331	340	348	356	365	373	382	391
Goodwill	524	524	524	524	523	523	523	523	523	523	523	523
Other Assets Noncurrent	10	9	8	7	6	6	6	4	4	5	5	5
Assets Noncurrent	973	984	992	1,001	1,027	1,042	1,051	1,059	1,066	1,084	1,091	1,110
Assets	1,347	1,360	1,375	1,394	1,601	1,638	1,641	1,643	1,640	1,681	1,678	1,695
Liabilities And Stockhold…
Liabilities Current
Accounts Payable Current	26	23	23	27	16	22	17	17	18	20	17	18
Employee Related Liabilities Current	41	48	51	49	39	62	52	51	35	53	48	46
Accrued Liabilities And Other Liabilities	13	12	17	18	19	13	23	17	18	15	19	18
Finance Lease Liability Current	-	-	-	-	-	-	-	-	-	0	0	0
Operating Lease Liability Current	5	5	5	4	3	3	4	4	4	6	6	7
Convertible Notes Payable Current	-	0	0	0	201	201	200	200	-	0	-	-
Contract With Customer Liability Current	1	1	2	1	1	0	1	1	1	2	4	6
Liabilities Of Disposal Group Including Discontinu…	-	-	0	0	-	-	-	-	-	-	-	-
Liabilities Current	85	88	98	100	280	301	296	290	77	96	93	95
Liabilities Noncurrent
Operating Lease Liability Noncurrent	61	63	64	67	60	61	62	63	65	68	62	65
Convertible Debt Noncurrent	342	342	341	341	341	340	340	340	539	538	537	537
Deferred Income Tax Liabilities Net	17	18	21	20	21	22	23	23	23	24	25	29
Other Liabilities Noncurrent	12	12	12	12	12	12	12	12	13	13	13	13
Liabilities Noncurrent	433	435	439	440	433	434	436	437	640	643	638	644
Liabilities	518	523	536	540	713	736	733	727	717	740	731	739
Stockholders Equity
Common Stock Value Outstanding	0	0	0	0	0	0	0	0	0	0	0	0
Additional Paid In Capital Common Stock	1,280	1,270	1,262	1,251	1,240	1,228	1,219	1,210	1,199	1,190	1,182	1,173
Accumulated Other Comprehensive Income Loss Net Of…	0	0	0	0	-0	-0	-1	-1	-1	-2	-2	-3
Retained Earnings Accumulated Deficit	-451	-434	-424	-397	-352	-326	-310	-293	-274	-247	-233	-214
Stockholders Equity	829	837	838	854	888	902	908	916	923	942	947	956
Liabilities And Stockholders Equity	1,347	1,360	1,375	1,394	1,601	1,638	1,641	1,643	1,640	1,681	1,678	1,695
Accumulated Depreciation Depletion And Amortizatio…	216	209	209	201	199	190	181	176	168	158	155	147
Common Stock Par Or Stated Value Per Share	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001
Common Stock Shares Authorized	250	250	250	250	250	250	250	250	250	250	250	250
Common Stock Shares Issued	130	129	129	129	128	129	128	128	127	128	127	127
Shares Outstanding	130	128	129	129	128	128	128	128	127	127	127	127

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2026	2.33%	23.39%	61.97%	-	-	-	-	-	-	-	-	-
2025	12.61%	6.38%	-5.17%	25.90%	62.29%	91.43%	15.73%	19.25%	28.93%	-31.12%	-32.78%	-21.68%
2024	2.30%	-5.39%	4.24%	-3.53%	-5.73%	-21.48%	18.75%	12.73%	-0.47%	-20.87%	-24.90%	-35.13%
2023	-1.48%	-11.95%	-5.42%	-0.98%	-19.71%	-11.16%	29.69%	10.44%	6.55%	-0.07%	-4.15%	7.28%
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 90+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Start free trial

Performance and Valuation Metrics

Metrics	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30
Liquidity Ratios
Current Ratio	4.42	4.26	3.91	3.92	2.05	1.98	1.99	2.01	7.48	6.20	6.32	6.16
Quick Ratio	3.79	3.70	3.39	3.35	1.86	1.82	1.85	1.87	6.97	5.76	5.86	5.73
Working Capital	289.09M	287.99M	284.60M	292.43M	294.24M	294.78M	293.84M	294.24M	497.19M	500.51M	494.02M	489.87M
Leverage & Debt
Debt to Equity	0.62	0.63	0.64	0.63	0.80	0.82	0.81	0.79	0.78	0.79	0.77	0.77
Interest Coverage TTM	-38.89	-30.88	-25.30	-19.78	-13.64	-13.92	-5.95	-5.70	-5.88	-6.11	-9.37	-13.58
Debt Ratio	0.38	0.38	0.39	0.39	0.45	0.45	0.45	0.44	0.44	0.44	0.44	0.44
Efficiency & Turnover
Asset Turnover TTM	0.51	0.49	0.47	0.45	0.41	0.40	0.39	0.38	0.36	0.35	0.33	0.32
Days Sales Outstanding TTM	77.95	77.73	78.93	79.36	79.12	77.85	80.49	79.02	77.44	77.41	77.67	78.31
Receivables Turnover TTM	4.68	4.70	4.62	4.60	4.61	4.69	4.53	4.62	4.71	4.72	4.70	4.66
Per Share Metrics
Diluted EPS TTM	-0.77	-0.84	-0.88	-0.81	-0.61	-0.62	-0.61	-0.62	-0.67	-0.70	-0.77	-0.91
Free Cash Flow Per Share TTM	-0.04	-0.17	-0.13	-0.15	-0.25	-0.27	-0.17	-0.24	-0.31	-0.24	-0.40	-0.51
Dividend Per Share TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Margin Metrics
Gross Profit Margin TTM	43.15%	43.21%	43.46%	43.91%	44.30%	43.92%	43.54%	42.64%	41.80%	41.34%	40.68%	39.96%
Operating Profit Margin TTM	-14.25%	-15.93%	-17.04%	-16.69%	-13.29%	-13.94%	-14.33%	-15.17%	-16.90%	-18.21%	-20.10%	-23.72%
Net Profit Margin TTM	-13.30%	-14.85%	-16.00%	-15.10%	-11.54%	-11.92%	-12.07%	-12.50%	-13.79%	-14.87%	-16.76%	-20.79%
Growth Metrics
Net Revenue Growth (1Y)	10.95%	10.11%	10.10%	9.70%	10.10%	11.65%	12.06%	13.89%	15.27%	16.07%	15.71%	12.73%
Net Income Growth (1Y)	27.87%	37.22%	45.98%	32.46%	-7.89%	-10.51%	-19.31%	-31.50%	-32.95%	-39.02%	-41.02%	-21.90%
EPS Growth (1Y)	26.09%	35.67%	44.32%	30.86%	-8.80%	-11.32%	-20.11%	-32.07%	-33.53%	-39.64%	-41.61%	-22.70%
Valuation Metrics
P/E TTM	-9.66	-13.95	-8.74	-8.99	-15.58	-26.51	-24.09	-22.32	-23.54	-23.08	-16.05	-17.57
P/B TTM	1.16	1.80	1.18	1.10	1.36	2.31	2.06	1.91	2.15	2.16	1.63	2.11
P/S TTM	1.28	2.07	1.40	1.36	1.80	3.16	2.91	2.79	3.25	3.43	2.69	3.65
Market Cap	958.41M	1.51B	991.36M	935.31M	1.21B	2.09B	1.87B	1.75B	1.98B	2.03B	1.55B	2.01B
Enterprise Value	1.15B	1.69B	1.17B	1.12B	1.40B	2.26B	2.05B	1.94B	2.19B	2.23B	1.78B	2.26B
Calculated Values
Free Cash Flow TTM	-5.09M	-21.78M	-17.05M	-19.17M	-32.37M	-34.04M	-21.51M	-29.73M	-39.59M	-30.71M	-49.65M	-64.00M
Net Debt	196.10M	182.24M	177.36M	186.37M	195.65M	174.10M	178.39M	184.57M	207.01M	195.71M	231.24M	247.69M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
Valuation Ratios
P/CF TTM
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2026-06-15Sale

Owner: Tetrault, Lynn A.

Title: -

Shares: 5,307

Price/Share: $11.10

Value: $58,907.70

Shares Owned: 86,115

Relationship: Director

Ownership: Direct

2026-06-09Sale

Owner: Tetrault, Lynn A.

Title: -

Shares: 5,307

Price/Share: $11.29

Value: $59,916.03

Shares Owned: 91,422

Relationship: Director

Ownership: Direct

2026-01-20Sale

Owner: Stone, Warren

Title: Pres & Chief Operating Officer

Shares: 22,128

Price/Share: $12.50

Value: $276,600.00

Shares Owned: 121,631

Relationship: Officer

Ownership: Direct

2025-11-25Sale

Owner: Olivo, Alicia C

Title: EVP, GC & Business Development

Shares: 20,916

Price/Share: $12.00

Value: $250,992.00

Shares Owned: 31,083

Relationship: Officer

Ownership: Direct

2025-10-16Sale

Owner: Olivo, Alicia C

Title: EVP, GC & Business Development

Shares: 4,918

Price/Share: $10.00

Value: $49,180.00

Shares Owned: 43,022

Relationship: Officer

Ownership: Direct

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2026-06-15	Tetrault, Lynn A.	Director	-	Direct	Sale	5,307	11.10	$58,907.70	86,115	4
2026-06-09	Tetrault, Lynn A.	Director	-	Direct	Sale	5,307	11.29	$59,916.03	91,422	4
2026-01-20	Stone, Warren	Officer	Pres & Chief Operating Officer	Direct	Sale	22,128	12.50	$276,600.00	121,631	4
2025-11-25	Olivo, Alicia C	Officer	EVP, GC & Business Development	Direct	Sale	20,916	12.00	$250,992.00	31,083	4
2025-10-16	Olivo, Alicia C	Officer	EVP, GC & Business Development	Direct	Sale	4,918	10.00	$49,180.00	43,022	4
2025-08-06	Sherman, Jeffrey Scott	Officer	Chief Financial Officer	Direct	Purchase	20,000	5.62	$112,400.00	188,332	4
2025-08-06	Zook, Anthony P.	Director,Officer	Chief Executive Officer	Direct	Purchase	17,900	5.58	$99,882.00	38,066	4
2025-05-27	Kelly, Michael Aaron	Director	-	Indirect	Purchase	5,000	7.60	$38,000.00	5,000	4
2025-05-12	Stone, Warren	Officer	Pres & Chief Operating Officer	Direct	Purchase	5,700	8.58	$48,906.00	108,280	4
2025-05-09	Tetrault, Lynn A.	Director	-	Indirect	Purchase	7,000	8.14	$56,980.00	7,000	4
2025-05-07	Kanovsky, Stephen M	Director	-	Direct	Purchase	4,000	7.78	$31,120.00	40,090	4
2025-05-06	Zook, Anthony P.	Director,Officer	Chief Executive Officer	Indirect	Purchase	18,900	7.88	$148,932.00	18,900	4
2025-05-05	Gunn, Neil	Director	-	Direct	Purchase	4,510	7.76	$35,000.01	15,846	4
2025-05-05	Perez, David Brian	Director	-	Indirect	Purchase	10,000	7.63	$76,300.00	10,000	4
2025-05-02	Sherman, Jeffrey Scott	Officer	Chief Financial Officer	Direct	Purchase	20,000	7.51	$150,200.00	158,494	4
2024-11-15	Olivo, Alicia C	Officer	General Counsel	Direct	Sale	5,175	15.36	$79,488.00	37,129	4
2024-08-15	Olivo, Alicia C	Officer	General Counsel	Direct	Sale	1,040	16.05	$16,692.00	43,813	4
2024-05-15	Olivo, Alicia C	Officer	General Counsel	Direct	Sale	1,049	15.74	$16,511.26	44,867	4
2024-03-04	Tetrault, Lynn A.	Director	-	Direct	Sale	6,112	15.97	$97,608.64	50,062	4
2024-02-15	Olivo, Alicia C	Officer	General Counsel	Direct	Sale	2,587	14.96	$38,701.52	34,866	4
2023-11-17	Olivo, Alicia C	Officer	General Counsel	Direct	Sale	2,669	18.39	$49,082.91	37,140	4
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2026-03-31

100.49%

Inst. Shares: 129,796,268

Shares Outstanding: 129,166,000

2025-12-31

97.58%

Inst. Shares: 124,997,154

Shares Outstanding: 128,101,000

2025-09-30

96.40%

Inst. Shares: 123,787,746

Shares Outstanding: 128,415,000

2025-06-30

92.87%

Inst. Shares: 118,824,298

Shares Outstanding: 127,949,000

2025-03-31

93.74%

Inst. Shares: 119,408,482

Shares Outstanding: 127,376,000

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2026-03-31	129,796,268	129,166,000	100.49%
2025-12-31	124,997,154	128,101,000	97.58%
2025-09-30	123,787,746	128,415,000	96.40%
2025-06-30	118,824,298	127,949,000	92.87%
2025-03-31	119,408,482	127,376,000	93.74%
2024-12-31	111,749,822	126,658,000	88.23%
2024-09-30	112,513,981	126,953,000	88.63%
2024-06-30	115,760,837	126,405,000	91.58%
2024-03-31	116,360,059	126,111,000	92.27%
2023-12-31	115,658,805	125,502,000	92.16%
2023-09-30	109,913,304	125,687,000	87.45%
2023-06-30	107,803,245	125,356,000	86.00%
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial

NEOGENOMICS INC (NEO) — SEC Financial Statements & Analysis

NEOGENOMICS INC (NEO) is a services-testing laboratories company, incorporated in NV. NEOGENOMICS INC trades on Nasdaq as: NEO. Based on its latest SEC filing (Form 10-Q, period ending 2026-03-31), NEOGENOMICS INC reported a 10.95% year-over-year revenue growth, a Gross Profit Margin of 43.15% (TTM), a Debt-to-Equity ratio of 0.62x, a Price-to-Sales (P/S) ratio of 1.28x (TTM), a Price-to-Book (P/B) ratio of 1.16 (TTM), at a market cap of $958.41M. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y: 10.95%
Gross Profit Margin TTM: 43.15%
Debt To Equity: 0.62x
P/S TTM: 1.28x
P/B TTM: 1.16
Market Cap: $958.41M

Data as of 2026-03-31 · Source: SEC EDGAR

Frequently Asked Questions

What industry is NEOGENOMICS INC in?

NEOGENOMICS INC (NEO) operates in the Services-Testing Laboratories industry.

What is NEO's market cap?

NEOGENOMICS INC (NEO) has a market capitalization of $958.41M as of 2026-03-31.

What exchange does NEO trade on?

NEOGENOMICS INC (NEO) trades on the Nasdaq.

Where is NEOGENOMICS INC incorporated?

NEOGENOMICS INC is incorporated in NV.

NEOGENOMICS INC (NEO) — SEC Financial Statements & Analysis

Frequently Asked Questions

Research Faster.Invest Smarter.

Research Faster.
Invest Smarter.